Affirmative Psychotherapy for Mental Health Issues
(EQuIP Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this 2-arm randomized controlled trial is to assess the efficacy of a 10-session lesbian, gay, bisexual, transgender, and queer (LGBTQ)-affirmative cognitive-behavioral psychotherapy (CBT) delivered via telehealth in a large sample of sexual minority women (SMW) in New York, New Jersey and Pennsylvania. The investigators will assess whether the EQuIP (Empowering Queer Identities in Psychotherapy) treatment demonstrates significant reductions in heavy drinking (HD) and mental health symptoms (e.g., depression) compared to LGBTQ-affirmative treatment-as-usual.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, it does exclude those currently receiving mental health treatment or alcohol/drug abuse treatment, except for mutual self-help groups.
What data supports the effectiveness of the treatment Affirmative Psychotherapy for Mental Health Issues?
Research indicates that LGBTQ-affirmative cognitive-behavioral therapy (CBT) can be effective in addressing mental health issues related to minority stress, as shown in a study on internet-based CBT for LGBTQ youth. Additionally, the development of fidelity processes for affirmative CBT interventions suggests a structured approach to ensuring effective implementation for LGBTQ+ populations.12345
Is LGBTQ-affirmative psychotherapy safe for humans?
How is LGBTQ-affirmative CBT different from other treatments for mental health issues?
LGBTQ-affirmative CBT is unique because it specifically incorporates cultural competence and affirmative practices to support LGBTQ+ individuals, addressing their unique experiences and challenges. This approach is not limited to sexual orientation-specific issues but is designed to be inclusive and applicable to all clients, enhancing the therapeutic process by acknowledging and affirming diverse identities.23456
Research Team
John E Pachankis, PhD
Principal Investigator
Yale University
Tonda Hughes, PhD
Principal Investigator
Columbia University
Eligibility Criteria
This trial is for sexual minority women in New York who speak English, drink heavily according to WHO standards, and have depression or anxiety. They must want to reduce drinking but not be in mental health treatment more than once a month or need detoxification.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 10 weekly sessions of LGBTQ-affirmative cognitive behavioral therapy delivered via telehealth
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- LGBTQ-affirmative Cognitive Behavioral Therapy (Cognitive Behavioral Therapy)
- LGBTQ-affirmative Treatment-As-Usual (Other)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
Nancy J. Brown
Yale University
Chief Medical Officer since 2020
MD from Yale School of Medicine
Peter Salovey
Yale University
Chief Executive Officer since 2013
PhD in Psychology from Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator
Dr. George F. Koob
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Chief Executive Officer since 2014
PhD in Neurobiology from the Scripps Research Institute
Dr. Patricia Powell
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Chief Medical Officer since 2015
MD from an accredited institution